Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?

To: Douglas who wrote (80)	3/16/1998 10:26:00 PM
From: BRAVEHEART	Read Replies (1) \| Respond to of 370

Hi All SMILE, The bad news is I won't be attending the meeting tomorrow. The cost of $900 is prohibitive. The good news is I learned what is going to be discussed. The TAIPET program as we know it will have a new twist. Previously the discovery had a negative concern whereby the treatment had septic shock as a serious concern. No longer. They found a mutation associated with the lipit A gene which treats Cancer without causing septic shock. They will file with the FDA for human clinical trials based on this new research. THIS IS BIG MY FRIENDS. BEST WISHES LONE WOLF